Picture of Cullinan Therapeutics logo

CGEM — Cullinan Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Cullinan Oncology Provides Corporate Update And Reports Q4

March 17 (Reuters) - Cullinan Oncology Inc  CGEM.O :
    * CULLINAN ONCOLOGY PROVIDES CORPORATE UPDATE AND REPORTS
FOURTH
QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
    * CULLINAN ONCOLOGY INC - CASH, CASH EQUIVALENTS AND
INVESTMENTS
WERE $430.9 MILLION AS OF DECEMBER 31, 2021
    * CULLINAN ONCOLOGY INC - EXPECT THAT THIS BALANCE WILL BE
SUFFICIENT TO FUND OPERATIONS THROUGH 2024
    * CULLINAN ONCOLOGY INC - QTRLY LOSS PER SHARE $0.74

Source text for Eikon:  ID:nGNX2NQWht 
Further company coverage:  CGEM.O

Recent news on Cullinan Therapeutics

See all news